4
Changes in Ownership
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000089
10% owner bought 500,000 shares at $4.00 ($2,000,000)
- 10% owner acquired 297,133 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Inscobee Inc. 10% owner | 2025-05-12 | Purchase | +500,000 | $4.00 | $2,000,000 | 1,984,616 | D |
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion | +182,002 | $2.60 | $473,205 | 4,316,618 | I |
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion | +71,090 | $2.60 | $184,834 | 4,387,708 | I |
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion | +44,041 | $2.60 | $114,507 | 2,028,657 | D |
| Derivatives | |||||||
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion · Convertible Promissory Note | −0 | 0 | I | ||
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion · Convertible Promissory Note | −0 | 0 | I | ||
| Inscobee Inc. 10% owner | 2025-05-12 | Conversion · Convertible Promissory Note | −0 | 0 | D | ||
| Open-market purchases · 500,000 sh · avg $4.00 · $2,000,000 | |||||||
Loading xslF345X05/primary_doc.xml…